The Competition Commission is investigating insulin manufacturers Novo Nordisk and Sanofi Aventis, raising concerns about accessibility to diabetes care.
Competition Commission probes insulin price fixing
Original Article by Tamar Kahn | Business Day | 4 March 2025
The Competition Commission is investigating insulin manufacturers Novo Nordisk and Sanofi Aventis, raising concerns about accessibility to diabetes care.
More Posts
Older Adults With HIV Set To Double By 2040
Older adults with HIV will nearly double by 2040. South Africa faces one of the sharpest rises, straining health systems.
Read more...
Rosebank Health Village Expands Growthpoint Portfolio
Rosebank Health Village, a R100 million Growthpoint and Epione development, brings specialists, diagnostics and day surgery together.
Read more...
Global HIV Funding Cuts Put AIDS Progress At Risk
Global HIV funding cuts pushed financing to a 20-year low in 2025, threatening prevention, research and the goal of ending AIDS by 2030.
Read more...